Genetic variants in SOCS2, a negative regulator of GH receptor signalling, were shown to impact adult height standard deviation scores of patients after r-hGH treatment for Turner syndrome (TS) and GHD (up to 0.7 higher) [26]. The gene discussed is GH1; the disease is Turner syndrome.